Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Novacea Gains Rights To Oral Vinorelbine From Pierre Fabre

July 26, 2005

By Jennifer Boggs

Advancis' Amoxicillin Pulsys Fails In Second Phase III Trial

July 25, 2005

By Jennifer Boggs

Advancis' Amoxicillin Pulsys Fails In Second Phase III Trial

July 25, 2005

By Jennifer Boggs

Dendreon Rises On Provenge Survival Data; Considers BLA

July 22, 2005

By Jennifer Boggs

Dendreon Rises On Provenge Survival Data; Considers BLA

July 22, 2005

By Jennifer Boggs

EPIX's Phase II Trial Delayed For Blood Clot Imaging Agent

July 21, 2005

By Jennifer Boggs

EPIX's Phase II Trial Delayed For Blood Clot Imaging Agent

July 21, 2005

By Jennifer Boggs

Ilypsa's Series B Adds $36M For Renal Disease Products

July 20, 2005

By Jennifer Boggs

Ilypsa's Series B Adds $36M For Renal Disease Products

July 20, 2005

By Jennifer Boggs

CombinatoRx Out-Licenses Oncology Drug To HenKan

July 19, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...